Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleShort-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial
- Where
- Xi'an
- Age
- 18 years and over
- People
- 360
- Run by
- Xiaoqin Luo
See details and how to joinNCT07087561 - Phase 2Taking peopleLow-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
- Where
- Sanming, Shanghai
- Age
- 60 years and over
- People
- 50
- Run by
- Ruijin Hospital
See details and how to joinNCT07085169 - Phase 2Taking peopleNeoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 143
- Run by
- Sun Yat-sen University
See details and how to joinNCT05571644 - Phase 1Taking peopleSafety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 15
- Run by
- West China Hospital
See details and how to joinNCT07076823 - No phaseTaking peopleEffect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Multicenter Randomized Controlled Trial
- Where
- Yangzhou
- Age
- 18 years to 80 years
- People
- 300
- Run by
- Northern Jiangsu People's Hospital
See details and how to joinNCT07071987 - Phase 3Taking peoplePlaned Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 186
- Run by
- West China Hospital
See details and how to joinNCT07070622 - Phase 2Not yet taking people in ChinaEfficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 44
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07070713 - No phaseTaking peopleDevelopment and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer:MetBio-CRC
- Where
- Shanghai
- Age
- 18 years and over
- People
- 250
- Run by
- Shanghai Minimally Invasive Surgery Center
See details and how to joinNCT07068529 - No phaseNot yet taking people in ChinaScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study Protocol
- Where
- Guangzhou
- Age
- 40 years to 75 years
- People
- 314
- Run by
- Sun Yat-sen University
See details and how to joinNCT06710860 - Phase 2Taking peopleThalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
- Where
- Chongqing
- Age
- 18 years to 75 years
- People
- 96
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT06279351 - Phase 2Not yet taking people in ChinaDual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 34
- Run by
- Sun Yat-sen University
See details and how to joinNCT07059338 - Early phase 1Taking peopleA Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 20
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07050394 - Phase 2Taking peopleLiposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
- Where
- Tianjin
- Age
- 18 years and over
- People
- 46
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07047560 - No phaseTaking peopleDevelopment and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy
- Where
- Beijing
- Age
- 40 years to 75 years
- People
- 150
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06957626 - Phase 2Taking peopleClinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
- Where
- Beijing
- Age
- 18 years and over
- People
- 30
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07044921 - No phaseNot yet taking people in ChinaEvaluating AI and Human Expert Decisions in Colorectal Cancer
- Where
- Beijing
- People
- 1,500
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07045207 - No phaseTaking peopleAn Exploratory Study on Gene Methylation Detection of Colorectal Cancer
- Where
- Hangzhou
- Age
- 40 years and over
- People
- 450
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT07033156 - No phaseTaking peopleThe Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
- Where
- Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Tianjin, Xi’an
- Age
- 18 years to 60 years
- People
- 1,200
- Run by
- RenJi Hospital
See details and how to joinNCT06081647 - Phase 1Not yet taking people in ChinaA Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 66
- Run by
- Shanghai Bao Pharmaceuticals Co., Ltd.
See details and how to joinNCT07036185 - Phase 2Taking peopleA Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
- Where
- Beijing, Shanghai
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06885385 - Phase 1/2Taking peoplectDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 64
- Run by
- Sun Yat-sen University
See details and how to joinNCT07012954 - Phase 1Taking peopleStudy on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 29
- Run by
- Ruijin Hospital
See details and how to joinNCT07035002 - Phase 1Not yet taking people in ChinaPD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
- Where
- Changchun
- Age
- 18 years to 75 years
- People
- 22
- Run by
- jiuwei cui
See details and how to joinNCT07031011 - Phase 2Taking peopleVitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
- Where
- Shanghai
- Age
- 18 years and over
- People
- 25
- Run by
- Fudan University
See details and how to joinNCT05771181 - No phaseTaking peopleOrgan Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 96
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06209099